NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $204,000 | -10.5% | 2,153 | -13.7% | 0.02% | -10.5% |
| Q2 2019 | $228,000 | -13.0% | 2,496 | -8.4% | 0.02% | -13.6% |
| Q1 2019 | $262,000 | +1.2% | 2,724 | -9.9% | 0.02% | -8.3% |
| Q4 2018 | $259,000 | -10.1% | 3,024 | -9.7% | 0.02% | 0.0% |
| Q3 2018 | $288,000 | +24.1% | 3,347 | +9.0% | 0.02% | +9.1% |
| Q2 2018 | $232,000 | -2.1% | 3,071 | +4.6% | 0.02% | -4.3% |
| Q1 2018 | $237,000 | -37.5% | 2,936 | -34.9% | 0.02% | -37.8% |
| Q4 2017 | $379,000 | +53.4% | 4,511 | +56.6% | 0.04% | +32.1% |
| Q3 2017 | $247,000 | -85.9% | 2,881 | -87.0% | 0.03% | -88.8% |
| Q3 2016 | $1,750,000 | +33.9% | 22,159 | +39.9% | 0.25% | +26.1% |
| Q2 2016 | $1,307,000 | +312.3% | 15,836 | +329.3% | 0.20% | +282.7% |
| Q4 2015 | $317,000 | +14.0% | 3,689 | +21.8% | 0.05% | +4.0% |
| Q3 2015 | $278,000 | +8.6% | 3,028 | +16.2% | 0.05% | +16.3% |
| Q2 2015 | $256,000 | – | 2,606 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |